Imunon (IMNN) Competitors

Cybin (NYSE:CYBN) and Imunon (NASDAQ:IMNN) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk, institutional ownership and community ranking.

Is CYBN or IMNN more profitable?

Cybin's return on equity of -37.58% beat Imunon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cybin	N/A	-37.58%	-36.59%
Imunon	N/A	-230.05%	-128.98%

Does the MarketBeat Community believe in CYBN or IMNN?

Imunon received 8 more outperform votes than Cybin when rated by MarketBeat users. However, 100.00% of users gave Cybin an outperform vote while only 89.29% of users gave Imunon an outperform vote.

Company	Underperform	Outperform
Cybin	Outperform Votes 17 100.00%	Underperform Votes No Votes
Imunon	Outperform Votes 25 89.29%	Underperform Votes 3 10.71%

Which has higher earnings & valuation, CYBN or IMNN?

Imunon has higher revenue and earnings than Cybin. Cybin is trading at a lower price-to-earnings ratio than Imunon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cybin	N/A	N/A	-$57.88M	-$4.38	-1.97
Imunon	$500K	56.84	-$19.51M	-$1.36	-1.19

Do analysts rate CYBN or IMNN?

Cybin presently has a consensus target price of $86.00, suggesting a potential upside of 894.22%. Imunon has a consensus target price of $15.50, suggesting a potential upside of 856.79%. Given Cybin's stronger consensus rating and higher possible upside, analysts clearly believe Cybin is more favorable than Imunon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cybin	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
Imunon	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Does the media prefer CYBN or IMNN?

In the previous week, Imunon had 2 more articles in the media than Cybin. MarketBeat recorded 7 mentions for Imunon and 5 mentions for Cybin. Cybin's average media sentiment score of 1.08 beat Imunon's score of 0.43 indicating that Cybin is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cybin	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Imunon	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility and risk, CYBN or IMNN?

Cybin has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, Imunon has a beta of 2.13, meaning that its stock price is 113% more volatile than the S&P 500.

Do institutionals and insiders hold more shares of CYBN or IMNN?

17.9% of Cybin shares are owned by institutional investors. Comparatively, 4.5% of Imunon shares are owned by institutional investors. 15.0% of Cybin shares are owned by company insiders. Comparatively, 5.0% of Imunon shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Cybin beats Imunon on 9 of the 16 factors compared between the two stocks.